BRYAN BALL
CIK 1766522 · See remarks · last filed 2026-05-18
BRYAN BALL is a corporate insider who has filed 20 SEC Form 4 insider transactions across 4 companies since 2019. The most recent filing shows the insider was granted $200.0K of WHWK on May 18, 2026. Across all open-market trades the lifetime net is −$502.5K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.0M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$2.01M
4
20
-$502.5K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| WHWK | See remarks | 448,126 | $4.47 | $2.01M | -$635.1K | 6 | 2026-05-18 |
| Whitehawk Therapeutics, Inc. (AADI) Delisted | See remarks | 202,853 | $2.05 | $415.8K | -$5.0K | 1 | 2025-03-04 |
| INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Chief Qual. Officer & SVP Ops. | 25,178 | $19.00 | $478.4K | $0 | 5 | 2022-07-13 |
| IMMUNOMEDICS INC (IMMU) Delisted | Chief Quality Officer | 0 | — | — | $137.6K | 6 | 2020-10-23 |
Recent Filings
20 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-18 | WHWK | Grant (A) | +51,020 | $200.0K | EDGAR |
| 2026-04-15 | WHWK | Sell (S) | −118,849 | -$427.9K | EDGAR |
| 2026-04-13 | WHWK | Sell (S) | −56,596 | -$201.1K | EDGAR |
| 2026-04-09 | WHWK | Notice (144) | −196,969 | -$650.0K | EDGAR |
| 2026-04-03 | WHWK | Mixed | +366,532 | $0 | EDGAR |
| 2026-03-10 | WHWK | Mixed | +3,166 | -$6.1K | EDGAR |
| 2025-04-03 | WHWK | Grant (A) | — | $0 | EDGAR |
| 2025-03-04 | Whitehawk Therapeutics, Inc. (AADI) Delisted | Mixed | +102,853 | $235.0K | EDGAR |
| 2025-03-03 | WHWK | Notice (144) | −2,147 | -$5.0K | EDGAR |
| 2022-07-13 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Tax (F) | −436 | -$6.4K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.